Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Mental Rotation and Motor Imagery Training in Multiple SclerosisCompleted
NCT07749690NAUpdated Aug 6, 2026
Sponsor: Abant Izzet Baysal University
Relapsing Remitting MS (RRMS)
Turkey (Türkiye)
A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple SclerosisNot Yet Recruiting
NCT07748637EARLY_Phase 1Updated Aug 6, 2026
Sponsor: Daishi Tian
Multiple Sclerosis (MS)
China
Application of ihMT MRI in Multiple SclerosisRecruiting
NCT03600779NAUpdated Aug 6, 2026
Sponsor: Assistance Publique Hopitaux De Marseille
Sclerosis, Multiple
France
WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple SclerosisActive Not Recruiting
NCT05755061Phase 1Updated Aug 6, 2026
Sponsor: Kessler Foundation
Multiple Sclerosis · Relapsing-remitting Multiple Sclerosis
United States
Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple SclerosisCompleted
NCT07390201NAUpdated Aug 5, 2026
Sponsor: Cairo University
Multiple Sclerosis
Egypt
Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple SclerosisCompleted
NCT06401928NAUpdated Aug 5, 2026
Sponsor: The National Brain Mapping Laboratory (NBML)
Multiple Sclerosis
Iran
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple SclerosisRecruiting
NCT07587125Phase 1Updated Aug 5, 2026
Sponsor: Xijing Hospital
Multiple Sclerosis (MS) Primary Progressive · Multiple Sclerosis · Multiple Sclerosis (MS) Secondary Progressive · Refractory Multiple Sclerosis
China
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMSCompleted
NCT04121221Phase 3Updated Aug 5, 2026
Sponsor: Mapi Pharma Ltd.
Multiple Sclerosis, Relapsing-Remitting
United States, Belarus, Bosnia and Herzegovina, Bulgaria, Estonia +5 more
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With ImmunosuppressantCompleted
NCT01392872NAUpdated Aug 5, 2026
Sponsor: University Hospital, Clermont-Ferrand
Multiple Sclerosis, Relapsing-Remitting
France
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple SclerosisRecruiting
NCT06197685NAUpdated Aug 5, 2026
Sponsor: Kessler Foundation
Multiple Sclerosis
United States
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.Recruiting
NCT07115017N/AUpdated Aug 4, 2026
Sponsor: Washington University School of Medicine
Multiple Sclerosis
United States
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMTTerminated
NCT03368664Phase 3Updated Aug 4, 2026
Sponsor: Genzyme, a Sanofi Company
Multiple Sclerosis
France, Italy, Poland, Russia, Turkey (Türkiye) +1 more
Cognition Evolution and MRI Markers in PPMS Patients on 2 YearsCompleted
NCT03455582NAUpdated Aug 4, 2026
Sponsor: University Hospital, Bordeaux
Multiple Sclerosis, Primary Progressive
France
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Active Not Recruiting
NCT06220201Phase 1Updated Aug 3, 2026
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Multiple Sclerosis · Myasthenia Gravis
United States, Belgium, France, Germany, Spain +1 more
Online Mindfulness-Based Cognitive Therapy for People With Multiple Sclerosis With Mild-Moderate DepressionNot Yet Recruiting
NCT07742579Phase 3Updated Aug 3, 2026
Sponsor: Robert Simpson
Multiple Sclerosis
Effectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS).Not Yet Recruiting
NCT07741864NAUpdated Aug 3, 2026
Sponsor: Hospital Universitario Virgen Macarena
Multiple Sclerosis · Pain · Pain Management
Spain
A Study of Treatment Patterns and Annualized Relapse Rate in Multiple Sclerosis Patients Who Escalate Versus Continue Disease-Modifying Therapies Following RelapseCompleted
NCT07743281N/AUpdated Aug 3, 2026
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
Understanding and Enhancing Human Health and MovementRecruiting
NCT07738978NAUpdated Jul 31, 2026
Sponsor: Louis Stokes VA Medical Center
Spinal Cord Injury · Stroke (CVA) or Transient Ischemic Attack · Multiple Sclerosis
United States
Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple SclerosisRecruiting
NCT07736482N/AUpdated Jul 31, 2026
Sponsor: Afyonkarahisar Health Sciences University
Multiple Sclerosis
Turkey (Türkiye)
Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple SclerosisCompleted
NCT07501520NAUpdated Jul 31, 2026
Sponsor: Firat University
Multiple Sclerosis (MS) - Relapsing-remitting · Mediterranean Diet
Turkey (Türkiye)
Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM IIIRecruiting
NCT07738120NAUpdated Jul 31, 2026
Sponsor: University of Vigo
Multiple Sclerosis · Exercise · Physical Therapy · Virtual Reality Exposure Therapy
Spain
Characterizing the Use of Ofatumumab in a Real World SettingCompleted
NCT05090033N/AUpdated Jul 31, 2026
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Australia
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruiting
NCT03816345Phase 1Updated Jul 31, 2026
Sponsor: National Cancer Institute (NCI)
Autoimmune Disease · Crohn Disease · Dermatomyositis · Hematopoietic and Lymphoid Cell Neoplasm
United States, Canada
A Study of Oxidative Pathways in MS FatigueCompleted
NCT02804594Phase 2Updated Jul 30, 2026
Sponsor: University of California, San Francisco
Progressive Multiple Sclerosis · Fatigue
United States
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple SclerosisRecruiting
NCT05344469N/AUpdated Jul 30, 2026
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
Germany

Previous page Next page